Advisors Asset Management, Inc. Ptc Therapeutics, Inc. Transaction History

Advisors Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$41.85 - $53.85 $14,270 - $18,362	-341 Reduced 5.53%	5,822 $292,000
Q2 2022 Aug 08, 2022	SELL	$25.6 - $45.23 $78,950 - $139,489	-3,084 Reduced 33.35%	6,163 $247,000
Q1 2022 May 17, 2022	SELL	$33.33 - $44.6 $44,595 - $59,674	-1,338 Reduced 12.64%	9,247 $345,000
Q4 2021 Feb 15, 2022	SELL	$35.36 - $41.86 $10,077 - $11,930	-285 Reduced 2.62%	10,585 $422,000
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $370 - $447	10 Added 0.09%	10,870 $404,000
Q2 2021 Jul 30, 2021	BUY	$37.95 - $49.37 $5,920 - $7,701	156 Added 1.46%	10,860 $459,000
Q1 2021 May 07, 2021	BUY	$46.8 - $68.92 $107,546 - $158,378	2,298 Added 27.34%	10,704 $507,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $240,615 - $339,349	5,017 Added 148.04%	8,406 $513,000
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $71,293 - $89,599	1,570 Added 86.31%	3,389 $158,000
Q2 2020 Aug 12, 2020	BUY	$42.56 - $54.98 $77,416 - $100,008	1,819 New	1,819 $92,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.